September 23, 2018


Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib

(AETOS Wire) -- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG®(brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA......

Continue Reading >

September 20, 2018


“Man of The Planet” Sergey Burlakov Visits Dubai Sports Medicine Facility

Sergey Burlakov, a Paralympic athlete and four-time amputee, visited nanoM on September 16th. nanoM is a sports and human performance facility that is the first of its kind in the world, and Burlakov visited to undergo a series of tests.

Karan Rekhi, Vice President - Operations of Emirates Healthcare, said, “An inspirational hero like Sergey proves that you can do anything you set your mind to. He passed our tests at nanoM with flying colors;"...

Continue Reading >

September 19, 2018


175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis

(AETOS Wire)-- Roughly 175 million Europeans have obstructive sleep apnoea, according to a late-breaking abstract presented by ResMed today at the European Respiratory Society’s annual ERS Congress in Paris. Leading researchers estimate 90 million Europeans have moderate to severe sleep apnoea, meaning they experience at least 15 breathing events an hour during sleep.

These statistics are based on the"...

Continue Reading >

September 18, 2018


Aster DM Healthcare partners with Afe Babalola University

Aster DM Healthcare, a leading integrated healthcare services provider in Asia, has entered into a partnership agreement with a leading university hospital in Nigeria. Aimed at addressing the need gaps in the Nigerian healthcare sector, the partnership with Afe Babalola University Ado Ekiti (ABUAD) will see the Company setting up centres of excellence across specialties and also a Telemedicine unit managed by Aster DM Healthcare’s internationally certified specialists, majority of whom are from Aster’s network"...

Continue Reading >

September 17, 2018


Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice1

(AETOS Wire)-- Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease (COPD) patients treated with Spiolto® (tiotropium/olodaterol) Respimat®, which were presented today at the European Respiratory Society (ERS) International Congress 2018 in Paris, France.1 Patients in the study reported both improved physical functioning and general condition and high satisfaction with their"...

Continue Reading >

September 17, 2018


MEDTEX: Foresee the Next Wave of Healthcare Revolution

(AETOS Wire)-- Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in global healthcare technology and provider. On November 29 - 30, MEDTEX will focus on 3 key trends: Intelligent Healthcare, Next-generation Biotherapeutics, and Bio-Innovation. Jointed by over 30 world-renowned experts.

At CEO forum, leaders from Merck, Teva, Hitachi, and Nvidia will"...

Continue Reading >

September 17, 2018


Biolog-id Branches out to the United States with a New Operational Center in Atlanta

(AETOS Wire)-- Biolog-id, a world leader in connected health solutions, today announced the establishment of its U.S. operational center in Atlanta. This new site will enable Biolog-id to continue the growth of its presence in North America and offer its business solutions in the biggest health market in the world.

Biolog-id LLC’s offices are located in Alpharetta, 15 minutes north of Atlanta, Georgia."...

Continue Reading >

September 16, 2018


Philips launches first app based portable ultrasound system in Africa

Philips Africa has announced the introduction of Lumify, its first App-Based ultrasound system that will extend the reach of ultrasound applications to a broader network of healthcare providers using mobile technology.

Unveiled in Nairobi, Kenya, the Philips’ Lumify is an entirely new way of delivering ultrasound technology to healthcare providers and their patients; offering high-quality imaging on a compatible smart device through a subscription"...

Continue Reading >

September 16, 2018


Clinical trial data for nintedanib in patients with advanced IPF published

  • INSTAGE® trial results published in the New England Journal of Medicine1
  • Trial provides clinical data on patients with IPF and severe impairment in gas exchange usually excluded from clinical trials1
  • Efficacy and safety profile of nintedanib in patients with advanced IPF was consistent with that observed in patients with less advanced disease in earlier trials1,2,3,4
  • Sildenafil plus nintedanib did not provide significant benefit versus nintedanib alone1


Continue Reading >

September 16, 2018


Opt for Stromal Vascular Fraction (SVF) Therapy to Treat Chronic Pain

A 31-year-old Caucasian male, a baseball player, was extremely active athletically and in great physical shape until he was struck with osteoarthritis of the right shoulder and left knee. While the young sportsman wanted to build his career in baseball, the increasing pain levels made it difficult for him to perform well. After having tried varied treatments, with no effective results, the young man opted for Stromal Vascular Fraction (SVF) treatment which not only reduced his painful symptoms but also increased his range"...

Continue Reading >

Forex News Headline

Forex Market Video